Download this PDF guide outlining key information on HCC risk assessment, screening, and surveillance in the setting of Hepatitis B infection.
Gain expert insight on practical approaches to HCC risk assessment, HCC screening and surveillance, and HCC management in the setting of patients with hepatitis B.
Watch this dynamic panel discussion on HCC risk, screening, surveillance, and management, in the setting of patients with hepatitis B.
亚太地区在评估 HBV 患者的 HCC 风险和跨学科管理方面的注意事项
Asia-Pacific considerations in assessing HCC risk in patients with HBV and interdisciplinary management of HCC.
Patients achieving a functional cure for chronic hepatitis B with nucleos(t)ide analogue treatment may still develop HCC. What tools do we have to predict which patients will experience progression of liver disease?
HCC risk scores can inform a personalized approach to HCC surveillance in patients with chronic hepatitis B by allowing patients at very low risk to avoid burdensome surveillance and identifying high-risk patients who may benefit from intensive surveillance
Learn from Grace LH Wong, MD, about prevention and treatment of HBV-related HCC in the Asia-Pacific region, where more than 75% of the global population with HBV resides.
In these slides, expert faculty discusses Asia-Pacific considerations relevant to patients with HCC in the setting of hepatitis B.